Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Priapism after tumor necrosis factor alpha inhibitor use.

Kreitenberg AJ, Ortiz EC, Arkfeld DG.

Clin Rheumatol. 2015 Apr;34(4):801-2. doi: 10.1007/s10067-014-2858-x. Epub 2015 Jan 13.

PMID:
25579651
2.

Reversal of chronic refractory tophaceous gout with erosions with pegloticase.

Yeter KC, Ortiz EC, Arkfeld DG.

Int J Rheum Dis. 2013 Jun;16(3):369-70. doi: 10.1111/1756-185X.12073. Epub 2013 May 23. No abstract available.

PMID:
23981765
3.

Evolution of classification criteria for rheumatoid arthritis: how do the 2010 criteria perform?

Ortiz EC, Shinada S.

Rheum Dis Clin North Am. 2012 May;38(2):345-53. doi: 10.1016/j.rdc.2012.05.004. Epub 2012 Jun 27. Review.

PMID:
22819088
4.

Later comes earlier, nowadays.

Ortiz EC, Torralba KD, O'Dell JR, Panush RS.

J Rheumatol. 2011 Nov;38(11):2287-9. doi: 10.3899/jrheum.111130. No abstract available.

PMID:
22045932
5.

Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.

Horton HM, Chu SY, Ortiz EC, Pong E, Cemerski S, Leung IW, Jacob N, Zalevsky J, Desjarlais JR, Stohl W, Szymkowski DE.

J Immunol. 2011 Apr 1;186(7):4223-33. doi: 10.4049/jimmunol.1003412. Epub 2011 Feb 28.

6.

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators..

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

Supplemental Content

Loading ...
Support Center